Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05PKR
|
||||
| Former ID |
DIB020182
|
||||
| Drug Name |
L-817,818
|
||||
| Synonyms |
L 817818; L817818; L-817818
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [539295] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C33H36N4O3
|
||||
| InChI |
InChI=1S/C33H36N4O3/c1-21(35)20-40-33(39)29(12-6-7-17-34)36-30(38)19-28-27-16-15-23-9-4-5-11-26(23)32(27)37-31(28)25-14-13-22-8-2-3-10-24(22)18-25/h2-5,8-11,13-16,18,21,29,37H,6-7,12,17,19-20,34-35H2,1H3,(H,36,38)/t21-,29-/m0/s1
|
||||
| InChIKey |
NFVRGDRCCNEGBS-LGGPFLRQSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Somatostatin receptor 1 | Target Info | Agonist | [534729] | |
| Somatostatin receptor type 5 | Target Info | Agonist | [534729] | ||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.